Abstract
To identify prognostic subgroups among nonfunctioning (nonsyndromic) pancreatic endocrine tumours, a series of 61 tumours were analysed systematically for macroscopic, histopathological and immunohistochemical variables potentially predictive of malignancy. High-grade nuclear atypia, elevated mitotic rate and multifocal necrosis allowed us to separate 5 poorly differentiated carcinomas from 56 well differentiated tumours. Among the latter, 29 well-differentiated carcinomas showing gross local invasion or metastases were identified. Vascular or perineural microinvasion, Ki67 proliferative index >2%, mitotic rate ≥2, size ≥4 cm, capsular penetration, nuclear atypia, lack of progesterone receptors and presence of calcitonin were among the variables correlated with malignancy. The first two were the most sensitive and specific. Their presence or absence was used in the 27 tumours lacking evidence of malignancy at the time of surgery to separate 11 cases with increased risk of malignancy (in 2 of which metastases developed during follow-up) from 16 cases with limited risk. The resulting four prognostic groups of nonfunctioning pancreatic endocrine tumours (limited- and increased-risk tumours, well-differentiated carcinomas and poorly differentiated carcinomas) showed distinct survival curves, which were significantly affected by vascular microinvasion, Ki67 proliferative index and metastases.
Similar content being viewed by others
References
Abbona GC, Papotti M, Gasparri G, Bussolati G (1995) Proliferative activity in parathyroid tumors as detected by Ki67 immunostaining. Hum Pathol 26:135–138
Bonato M, Cerati M, Pagani A, Papotti M, Bosi F, Bussolati G, Capella C (1992) Differential diagnostic patterns of lung neuroendocrine tumors. A clinico-pathologic and immunohistochemical study of 122 cases. Virchows Arch [A] 420:201–211
Bordi C, Pilato FP, D'Adda T (1988) Comparative study of seven neuroendocrine markers in pancreatic endocrine tumors. Virchows Arch [A] 413:387–398
Broder LE, Carter SK (1973) Pancreatic islet cell carcinoma. Clinical features of 52 patients. Ann Intern Med 79:101–107
Broughan TA, Leslie JD, Soto JM, Herman RE (1986) Pancreatic islet cell tumors. Surgery 99:671–678
Capella C, Riva C, Rindi G, Sessa F, Usellini L, Chiaravalli AM, Carnevali L, Solcia E (1991) Histopathology, hormone products and clinico-pathologic profile of endocrine tumors of the upper small intestine: a study of 44 cases. Endocr Pathol 2:92–110
Capella C, Heitz PU, Höfler H, Solcia E, Klöppel G (1995) Revised classification of neuroendocrine tumors of the lung, pancreas and gut. Virchows Arch 425:547–560
Chejfec G, Falkmer S, Askensten U, Grimelius L, Gould VE (1988) Neuroendocrine tumors of the gastrointestinal tract. Pathol Res Pract 183:143–154
Costes V, Marthy-Anè C, Picot MC, Sure I, Rojol JL, Mary H, Baldet P (1995) Typical and atypical bronchopulmonary carcinoid tumors: a clinicopathologic and Ki67 labelling study. Hum Pathol 26:740–745
Donow C, Baisch H, Heitz PU, Klöppel G (1991) Nuclear DNA content in 27 pancreatic endocrine tumours: correlation with malignancy, survival and expression of glycoprotein hormone alpha chain. Virchows Arch [A] 419:463–468
Frantz VK (1940) Tumors of islet cells with hyperinsulinism: benign, malignant and questionable. Ann Surg 112:116–176
Goldblum JR, Shannon R, Kaldijian EP, Thiny M, Davenport R, Thompson N, Lloyd RV (1993) Immunohistochemical assessment of proliferative activity in adrenocortical neoplasms. Mod Pathol 6:663–668
Grimelius L, Hultquist GT, Stenkvist B (1975) Cytological differentiation of asymptomatic pancreatic islet cell tumours in autopsy material. Virchows Arch [A] 365:275–288
Heitz PU (1991) Pancreatic endocrine tumors. In: Klöppel G, Heitz PU (eds) Pancreatic pathology. Churchill Livingstone, Edinburgh, pp 206–232
Heitz PU, Kasper M, Polak JM, Klöppel G (1982) Pancreatic endocrine tumors: immunocytochemical analysis of 125 tumors. Hum Pathol 13:263–271
Heitz PU, Kasper M, Klöppel G, Polak JM, Vaitukaitis JL (1983) Glycoprotein-hormone alpha-chain production by pancreatic endocrine tumors: a specific marker for malignancy. Cancer 51:277–282
Höfler H, Ruhri C, Pütz B, Wirnsberger G, Hauser H (1988) Oncogene expression in endocrine pancreatic tumors. Virchows Arch [B] 55:355–361
Hsu SM, Raine L, Fanger H (1980) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. J Histochem Cytochem 25:577–580
Kahn R, Rosen SW, Weintraub BD, Fajans SS, Gorden P (1977) Ectopic production of chorionic gonadotropin and its subunits by islet cell tumors. N Engl J Med 297:565–569
Kenny BD, Sloan JM, Hamilton PW, Watt PCH, Johnston CF, Buchanan KD (1989) The role of morphometry in predicting prognosis in pancreatic islet cell tumors. Cancer 64:460–465
Kent RB, Van Heerden JA, Weiland LH (1981) Nonfunctioning islet cell tumors. Ann Surg 193:185–190
Kimura N, Miura W, Noshiro T, Miura Y, Ookuma T, Nagura H (1994) Ki67 is an indicator of progression of neuroendocrine tumors. Endocr Pathol 5:223–228
Kitz K, Knosp E, Koos WT, et al (1991) Proliferation of pituitary adenomas: measurement by Mab Ki-67. Acta Neurochir 53 [Suppl]:60–64
Klöppel G, Heitz PU (1988) Pancreatic endocrine tumors. Pathol Res Pract 183:155–168
Kramer A, Saeger W, Tallen G, Ludecke DK (1994) DNA measurement, proliferation markers and other factors in pituitary adenomas. Endocr Pathol 5:198–211
Landolt AM, Shibata T, Kleihues P (1987) Growth rate of human pituitary adenomas. J Neurosurg 67:803–806
La Rosa S, Sessa F, Bosi F, Fabbri A, Capella C (1995) Prognostic factors in nonfunctioning pancreatic endocrine tumors. Lab Invest 72:54A
Larsson LI (1978) Endocrine pancreatic tumors. Hum Pathol 401–416
Liu T, Zhu Y, Cyi Q, Cui L, Ye S, Zhong S, Jia H (1992) Non-functioning pancreatic endocrine tumors. An immunohistochemical and electron microscopic analysis of 26 cases. Pathol Res Pract 188:191–198
Lopez-Krunger R, Dockerty MB (1947) Tumors of the islets of Langerhans. Surg Gynecol Obstet 85:495–511
McNicol AM, Colgan J, McMeekin W, Teasdale GM (1989) Nucleolar organizer regions in pituitary adenomas. Acta Neuropathol 77:547–549
Nairn ER, Crocker J, McGovern J (1988) Limited value of Ag-NOR enumeration in assessment of thyroid neoplasms. J Clin Pathol 41:1136
Pelosi G, Zamboni G, Doglioni C, Rodella S, Bresaola E, Iacono C, Serio G, Iannucci A, Scarpa A (1992) Immunodetection of proliferating cell nuclear antigen assesses the growth fraction and predicts malignancy in endocrine tumors of the pancreas. Am J Surg Pathol 16:1215–1225
Prinz RA, Badrinath R, Chejfec G, Freark RJ, Grenlee HB (1983) “Nonfunctioning” islet cell carcinoma of the pancreas. Am Surg 49:345–349
Reyes CV, Wang T (1981) Undifferentiated small cell carcinoma of the pancreas: a report of five cases. Cancer 47:2500–2502
Rindi G, Luinetti O, Cornaggia M, Capella C, Solcia E (1993) Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study. Gastroenterology 104:994–1006
Rosai J, Carcangiu ML, DeLellis RA (1992) Tumors of the thyroid gland. Rosai J (ed) Atlas of tumor pathology, 3rd series, fasc 5. Armed Forces Institute of Pathology, Washington, DC
Rüschoff J, Willemer S, Brunzel M, Trautmann ME, Frank M, Arnold R, Klöppel G (1993) Nucleolar organizer regions and glycoprotein-hormone alpha-chain reaction as markers of malignancy in endocrine tumors of the pancreas. Histopathology 22:51–57
Ruttman E, Klöppel G, Bommer G, Kiehn M, Heitz PU (1980) Pancreatic glucagonoma with and without syndrome. Immunocytochemical study of 5 tumor cases and review of the literature. Virchows Arch [A] 388:51–67
Soga J, Tazawa K (1971) Pathologic analysis of carcinoids. Histologic revaluation of 62 cases. Cancer 28:990–998
Solcia E, Sessa F, Rindi G, Bonato M, Capella C (1991) Pancreatic endocrine tumors: general concepts; nonfunctioning tumors and tumors with uncommon function. In: Dayal Y (ed) Endocrine pathology of the gut and pancreas. CRC Press, Boca Raton, Fla, pp 105–131
Stamm B, Häcki WH, Klöppel G, Heitz PU (1991) Gastrin producing tumors and Zollinger-Ellison syndrome. In: Dayal Y (ed) Endocrine pathology of the gut and pancreas. CRC Press, Boca Raton, Fla, pp 155–194
Stefaneanu L, Horvath E, Kovacs K (1989) Argyrophil organizer region proteins (AGNORs) in adenohypophysial cells and adenomas of the human pituitary. Mod Pathol 2:192–199
Stefanini P, Carboni M, Patrassi N, Basoli A (1974) Beta-islet cell tumors of the pancreas. Results of a study on 1067 cases. Surgery 75:597–609
Strodel WE, Vinik AI, Lloyd RV, Glaser B, Eckhauser FE, Fiddian-Green RG, Turcotte JG, Thompson NW (1984) Pancreatic polypeptide-producing tumors. Silent lesions of the pancreas? Arch Surg 119:508–514
Van Heerden JA, Hay ID, Goellener JR, Salomao D, Ebersold JR, Bergstrahl EJ, Grant CS (1992) Follicular thyroid cercinoma with capsular invasion alone: a nonthreatening malignancy. Surgery 112:1130–1138
Viale G, Doglioni C, Gambacorta M, Zamboni G, Coggi G, Bordi C (1992) Progesterone receptors immunoreactivity in pancreatic endocrine tumors. Cancer 70:2268–2277
Vollmer RT (1996) Multivariate statistical analysis for pathologists. Am J Clin Pathol 105:115–126
Wilander E, El-Salhy M, Willen R, Grimelius L (1981) Immunohistochemistry and electron microscopy of an argentaffin endocrine tumour of the pancreas. Virchows Arch [A] 292:263–269
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
La Rosa, S., Capella, C., Sessa, F. et al. Prognostic criteria in nonfunctioning pancreatic endocrine tumours. Vichows Archiv A Pathol Anat 429, 323–333 (1996). https://doi.org/10.1007/BF00198436
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00198436